arcoris bio is developing MUSE, a nanotechnology platform for multiplexed biomarker detection in research and diagnostics. The CHF 6.3 million seed round, in which private investors also took part, will fund industrialisation and new products.
- Announced on
- Round
- Seed
- Amount
- CHF 6.3 M
- Location
- Schlieren, canton of Zurich
Investors
- Ventura Ace lead
- ZEISS Ventures lead
- Zürcher Kantonalbank
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic